Engineers Gate Manager’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$670K Sell
53,554
-16,917
-24% -$227K 0.01% 1328
2026
Q1
$1.05M Buy
70,471
+44,264
+169% +$985K 0.01% 1026
2025
Q4
$655K Buy
+26,207
New +$466K 0.01% 1235
2025
Q1
Sell
-16,310
Closed -$95.1K 2455
2024
Q4
$95.1K Buy
+16,310
New +$163K ﹤0.01% 2006
2024
Q1
Sell
-27,462
Closed -$385K 2196
2023
Q4
$385K Buy
+27,462
New +$369K 0.01% 1312

Other funds holding OLMA

Engineers Gate Manager's OLMA Position: Q2 2026 in Review

Engineers Gate Manager reduced its Olema Pharmaceuticals (OLMA) stake by 24% in Q2 2026, selling an estimated $227K and leaving 53,554 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #1328.

Engineers Gate Manager first reported a position in OLMA in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.05M in Q1 2026. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Engineers Gate Manager held 53,554 shares of Olema Pharmaceuticals worth $670K as of Q2 2026.
  • Engineers Gate Manager sold 16,917 Olema Pharmaceuticals shares in Q2 2026, an estimated $227K.
  • Olema Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1328 holding.
  • Engineers Gate Manager first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Engineers Gate Manager's Olema Pharmaceuticals position peaked at $1.05M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.